Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, UK.
School of Engineering and Materials Science, Queen Mary University of London, London, UK.
Cancer Discov. 2018 Mar;8(3):304-319. doi: 10.1158/2159-8290.CD-17-0284. Epub 2017 Dec 1.
We have profiled, for the first time, an evolving human metastatic microenvironment by measuring gene expression, matrisome proteomics, cytokine and chemokine levels, cellularity, extracellular matrix organization, and biomechanical properties, all on the same sample. Using biopsies of high-grade serous ovarian cancer metastases that ranged from minimal to extensive disease, we show how nonmalignant cell densities and cytokine networks evolve with disease progression. Multivariate integration of the different components allowed us to define, for the first time, gene and protein profiles that predict extent of disease and tissue stiffness, while also revealing the complexity and dynamic nature of matrisome remodeling during development of metastases. Although we studied a single metastatic site from one human malignancy, a pattern of expression of 22 matrisome genes distinguished patients with a shorter overall survival in ovarian and 12 other primary solid cancers, suggesting that there may be a common matrix response to human cancer. Conducting multilevel analysis with data integration on biopsies with a range of disease involvement identifies important features of the evolving tumor microenvironment. The data suggest that despite the large spectrum of genomic alterations, some human malignancies may have a common and potentially targetable matrix response that influences the course of disease. .
我们首次通过测量基因表达、基质蛋白质组学、细胞因子和趋化因子水平、细胞密度、细胞外基质组织和生物力学特性,在同一样本上对不断演变的人类转移性微环境进行了描绘。我们使用从轻度到重度疾病范围的高级别浆液性卵巢癌转移的活检样本,展示了非恶性细胞密度和细胞因子网络如何随着疾病的进展而演变。不同成分的多元整合使我们能够首次定义可预测疾病程度和组织硬度的基因和蛋白质特征,同时还揭示了基质重塑在转移发展过程中的复杂性和动态性质。虽然我们研究了来自一种人类恶性肿瘤的单一转移性部位,但 22 种基质基因的表达模式将卵巢癌和其他 12 种原发性实体癌患者的总生存期区分开来,这表明可能存在一种对人类癌症的共同基质反应。对不同疾病参与程度的活检进行多层次分析和数据整合,可以识别不断演变的肿瘤微环境的重要特征。这些数据表明,尽管存在大量的基因组改变,但一些人类恶性肿瘤可能具有共同的、潜在可靶向的基质反应,这会影响疾病的进程。